Sandymount Therapeutics Ltd
13514842
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/06/2025
dormant
Next accounts due
31/03/2027
Confirmation statement
Last: 15/07/2025
Due 29/07/2026
Industry
Officers
director · Since 30/12/2025
BRITISH · UNITED KINGDOM · Age 51
Also on 4 other boards
Former
director · Resigned 31/12/2021
director · Resigned 18/06/2022
director · Resigned 18/06/2022
director · Resigned 09/02/2024
director · Resigned 09/02/2024
director · Resigned 30/12/2025
director · Resigned 30/12/2025
director · Resigned 03/07/2026
director · Resigned 03/07/2026
Persons with Significant Control
Dark Blue Therapeutics Ltd
46, Woodstock Road, Oxford, OX2 6HT
Reg: 12645831 · Uk Register Of Companies · Private Company Limited By Shares
Notified 16/07/2021
Change History
Active
Private Limited Company
HAYAKAWA BUILDING,
OXFORD
CompanyRankvs 3265+ SIC 72110 peers29
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£1
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—
Balance Sheet